COVID-19(14) death(8) moderate(8) effective(8) SARS-CoV-2(8) vaccine.(7) monoclonal antibodies(6) Postherpetic neuralgia(6) clinical trial(6) HZ/su vaccine(6) Immunotherapy(6) herpes zoster(6) IL-6(5) Cytokine release syndrome(5) monoclonal antibody(5) pandemic(5) etesevimab(5) bamlanivimab(5) Randomized(4) not effective(4) 95% CI(4) patients(4) COVID-19 illness(4) cytokine release(4) acute respiratory distress(4) expert(4) Hospitalization(4) FIVE(4) immune hyperactivation(4) required(4)